WSFG
BIIB icon

Wall Street Financial Group’s Biogen BIIB Stock Holding History

Wall Street Financial Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-224
Closed -$41.1K – 174
2026
Q1 		$41.1K Buy
+224
New +$41.3K 0.02% 355

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Wall Street Financial Group's BIIB Position: Q2 2026 in Review

Wall Street Financial Group sold out of Biogen (BIIB) in Q2 2026, closing a stake of 224 shares — an estimated $41.1K sold.

Wall Street Financial Group first reported a position in BIIB in Q1 2026 and held it in 1 quarter. The position peaked at $41.1K in Q1 2026. 621 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Wall Street Financial Group reported no remaining Biogen position as of Q2 2026 after selling out during the quarter.
  • Wall Street Financial Group sold 224 Biogen shares in Q2 2026, an estimated $41.1K.
  • Wall Street Financial Group first reported a position in Biogen in Q1 2026 and held it in 1 quarter.
  • Wall Street Financial Group's Biogen position peaked at $41.1K in Q1 2026.
  • 621 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Wall Street Financial Group's 13F filing for Q2 2026, filed 14 Jul 2026.